Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

NEON

Neonmind Biosciences (NEON)

Neonmind Biosciences inc
Date:
Sort by:
 Showing the most relevant articles for your search:CSE:NEON
DateTimeSourceHeadlineSymbolCompany
09/28/20215:45AMInvestorsHub NewsWireNeonMind Advances Strategy for Specialty Clinic LaunchCSE:NEONNeonmind Biosciences inc
09/22/20215:30AMInvestorsHub NewsWireNeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhDCSE:NEONNeonmind Biosciences inc
09/16/202110:39AMInvestorsHub NewsWireNeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory BoardCSE:NEONNeonmind Biosciences inc
09/08/20215:31AMInvestorsHub NewsWireNeonMind to Present at H.C. Wainwright 23rd Annual Global Investment ConferenceCSE:NEONNeonmind Biosciences inc
07/28/20216:03AMInvestorsHub NewsWireDr. Sagar Parikh, MD Appointed to NeonMind Specialty Clinics Advisory BoardCSE:NEONNeonmind Biosciences inc
06/29/20217:50AMInvestorsHub NewsWireNeonMind Announces Launch of Functional Mushroom Coffees as Dietary Supplements in the USCSE:NEONNeonmind Biosciences inc
06/10/20216:57AMInvestorsHub NewsWireNeonMind Announces Vitasave Will Carry NeonMind Functional Mushroom ProductsCSE:NEONNeonmind Biosciences inc
05/28/20217:24AMInvestorsHub NewsWireNeonMind to Commence Trading on the OTCQB Venture MarketCSE:NEONNeonmind Biosciences inc
04/06/20217:10AMInvestorsHub NewsWireNeonMind Developing Music Playlist for Psychedelic Therapy SessionsCSE:NEONNeonmind Biosciences inc
03/09/20217:00AMInvestorsHub NewsWireNeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for ObesityCSE:NEONNeonmind Biosciences inc
02/24/20217:04AMInvestorsHub NewsWireNeonMind Purchases GMP Grade Synthetic Psilocybin from Psygen Labs for Phase 2 Human Clinical TrialCSE:NEONNeonmind Biosciences inc
01/27/20217:04AMInvestorsHub NewsWireNeonMind Appoints Robert Tessarolo as President and Chief Executive OfficerCSE:NEONNeonmind Biosciences inc
 Showing the most relevant articles for your search:CSE:NEON